Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Two-Stage Study to Assess the Efficacy and Safety of 3 Doses of Crofelemer Orally Twice Daily for the Treatment of HIV-Associated Diarrhea

Trial Profile

Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Two-Stage Study to Assess the Efficacy and Safety of 3 Doses of Crofelemer Orally Twice Daily for the Treatment of HIV-Associated Diarrhea

Completed
Phase of Trial: Phase III

Latest Information Update: 24 Jul 2017

At a glance

  • Drugs Crofelemer (Primary)
  • Indications Diarrhoea
  • Focus Registrational; Therapeutic Use
  • Acronyms ADVENT
  • Sponsors Salix Pharmaceuticals
  • Most Recent Events

    • 24 Jul 2017 Results published in a Napo Pharmaceuticals media release.
    • 24 Jul 2017 According to a Napo Pharmaceuticals media release, the results of a supplemental analysis were reported at the 9th International AIDS Society (IAS) Conference on HIV Science.
    • 14 Jan 2014 Results have been published in HIV Clinical Trials, according to a Salix Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top